Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin

Publisher： Karger

E-ISSN： 1421-9786|32|1|22-27

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.32, Iss.1, 2011-05, pp. : 22-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Systematic Reviews and Meta-Analyses of Acupuncture for Stroke

By  

Neuroepidemiology, Vol. 42, Iss. 1, 2013-12 ,pp. : 50-58

Karger

Access to resources Recommend Favorite

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

By  

Cerebrovascular Diseases, Vol. 39, Iss. 1, 2014-12 ,pp. : 13-22

Karger

Access to resources Recommend Favorite

Incidence, Risk Factors and Prognosis of Stroke and TIA: The Need for High-Quality, Large-Scale Epidemiological Studies and Meta-Analyses

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 2-10

Karger

Access to resources Recommend Favorite

Aspirin and ticlopidine for prevention of recurrent stroke in black patients

By Gorelick P.B.   Richardson D.   Kelly M.   for the African American Antiplatelet Stroke Prevention Study AAASPS Investigators.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 30-31

Elsevier

Access to resources Recommend Favorite